Reverse-Cyte 3% (A1, B) 2x10 ml
by Medion Grifols Diagnostics AG
Reverse-Cyte 3% (A1, B) 2x10 ml (213635) is a medical device made by Medion Grifols Diagnostics AG, listed in FDA GUDID since 27 Jan 2016 (UDI-DI 07640137340292), registry data as of 23 Oct 2026.
Listed
Valid until
Not applicable
FDA recalls
Not checked
Documents
None
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number07640137340292 | Date27 Jan 2016 | StatusListed |
Official records
- AccessGUDID record 07640137340292
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — GUDID listing Listed
Specification
- Trade name
- Reverse-Cyte 3% (A1, B)
- Generic name
- Reverse ABO grouping reagent red blood cell (A1/A2/B/AB/O) IVD, kit, agglutination
- Model / Ref / Catalog
- 2x10 ml, 213635
- Primary DI / UDI-DI
- 07640137340292
- GMDN term
- Reverse ABO grouping reagent red blood cell (A1/A2/B/AB/O) IVD, kit, agglutination
- GUDID distribution status
- In Commercial Distribution